Explore the latest in venous thromboembolism, including the latest in risk prediction and management with newer oral anticoagulants.
This report of a case describes a man in his 70s with type 2 diabetes, hypertension, and hyperlipidemia who presented to the emergency department with 4 days of progressive dizziness, shortness of breath, and chest pain on exertion.
This study uses 3 distinct statistical approaches to examine the association between use of inferior vena cava filters and mortality rates in Medicare fee-for-service beneficiaries with pulmonary embolism.
This Viewpoint analyzes data on the thrombotic risk associated with cyclin-dependent kinase inhibitors and notes the need for additional research on the thrombotic risk of these drugs, the influence of combined drug therapy on thrombotic risk, and patient selection.
This analysis of data from the Emerging Risk Factors Collaboration and the UK Biobank estimates the associations of major cardiovascular risk factors with venous thromboembolism.
This cohort study examines whether aspirin as a single agent is inferior to other anticoagulation agents for reducing the risk of venous thromboembolism or major bleeding events after unilateral primary total knee arthroplasty.
This Clinical Evidence Synopsis summarizes a Cochrane review of randomized trials comparing the effects of treatment of lower extremity superficial thrombophlebitis on venous thromboembolism and major bleeding.
This population-based analysis uses data from a US nationwide insurance claims database to assess the risk of venous thromboembolism associated with keratinocyte carcinoma within 1 year following the date of diagnosis and compares rates of venous thromboembolism among patients with or without cancer.
This pre-post intervention comparison study evaluates a real-time patient-centered education bundle intervention aimed to reduce nonadministration of venous thromboembolism prophylaxis among hospitalized patients in surgical and medical units.
This cohort study compares the risk for venous thromboembolism among women who use extended cyclic and continuous combined oral contraceptives (COCs) with that among women who use traditional cyclic COCs, while holding the progestogen type constant.
This narrative review summarizes advances in diagnosis and treatment of venous thromboembolism (VTE), including use of age-adjusted D-dimer levels and rule-out criteria (PERC) to exclude the diagnosis, use of newer oral anticoagulants (NOACs) as treatment, and indications for thrombolysis.
This Medical Letter review summarizes approved indications, doses, adverse effects, and costs of warfarin and newer oral anticoagulants used to treat venous thromboembolism.
This randomized clinical trial evaluates the incidence of postoperative venous thromboembolism and use of venous thromboembolism prevention methods among Korean patients with gastric cancer.
This cohort study uses Swedish national databases to assess major bleeding and venous thromboembolism (VTE) following hip and knee replacement surgical procedures in patients with and without a family history of VTE.
This cohort study uses ACS-NSQUIP registry data to examine the association between perioperative red blood cell transfusions and postoperative venous thromboembolism within 30 days of surgery among North American patients undergoing surgery.
This cohort study examines how often clinicians opt for clinical surveillance over therapeutic anticoagulation for patients with subsegmental pulmonary embolisms.
This study examines the use of pharmacologic and mechanical prophylaxis in hospitalized patients at low and high risk for venous thromboembolism.
This comparative effectiveness cohort study explores the association of inferior vena cava filter placement with 30-day mortality in patients with venous thromboembolic disease and a contraindication to anticoagulation.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: